340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
Politicians in Washington have very short memories, so they repeat the same mistakes over and over.
It was only 17 years ago that the "subprime" mortgage crisis torpedoed the economy and sent the financial markets into the biggest tailspin since the Great Depression. Millions of Americans lost their jobs. One of the matches that lit that bonfire was Freddie Mac and its cousin, Fannie Mae, offering generous, taxpayer-guaranteed mortgage insurance to risky borrowers on loans with low down payments.
It all blew up in the faces of the taxpayers even though the Washington experts said the…
